Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Mar 16;42(1):167.
doi: 10.1007/s00345-024-04905-6.

Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening

Takeshi Takahashi  1
Affiliations
Comment

Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening

Takeshi Takahashi. World J Urol. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Kwe J, Baunacke M, Boehm K, Platzek I, Thomas C, Borkowetz A (2024) PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions. World J Urol 42(1):84. https://doi.org/10.1007/s00345-024-04776-x - DOI - PubMed - PMC
    1. Young RH, Eble JN (2019) The history of urologic pathology: an overview. Histopathology 74(1):184–212. https://doi.org/10.1111/his.13753 - DOI - PubMed
    1. Epstein JI, Allsbrook WC, Amin MB, Egevad LL (2005) ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29(9):1228–1242. https://doi.org/10.1097/01.pas.0000173646.99337.b1 - DOI - PubMed
    1. Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-specific antigen-based screening for prostate cancer: a systematic evidence review for the U.S. preventive services task force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. Report No.: 17–05229-EF-1.
    1. Catalona WJ (2018) Prostate cancer screening. Med Clin North Am 102(2):199–214. https://doi.org/10.1016/j.mcna.2017.11.001 - DOI - PubMed - PMC

Substances

LinkOut - more resources